HuGE Literature Finder
|
||
Records 1-17
|
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
European journal of cancer (Oxford, England : 1990) 2019 Aug 120 31-39. Chae Heejung, Kim Deokhoon, Yoo Changhoon, Kim Kyu-Pyo, Jeong Jae Ho, Chang Heung-Moon, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Hwang Shin, Kim Ki-Hun, Song Gi-Won, Ahn Chul Soo, Lee Jae Hoon, Hwang Dae Wook, Kim Song Cheol, Jang Se Jin, Hong Seung-Mo, Kim Tae Won, Ryoo Baek-Ye |
|
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?
HPB : the official journal of the International Hepato Pancreato Biliary Association 2019 May . Bagante Fabio, Ruzzenente Andrea, Conci Simone, Rusev Borislav C, Simbolo Michele, Campagnaro Tommaso, Pawlik Timothy M, Luchini Claudio, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
|
Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
Human pathology 2018 Apr . Chi Zhikai, Bhalla Amarpreet, Saeed Omer, Cheng Liang, Curless Kendra, Wang Hanlin L, Patil Deepa T, Lin Jingm |
|
Clinicopathologic, Radiologic, and Molecular Study of 23 Combined Hepatocellular-Cholangiocarcinomas with Stem Cell Features, Cholangiolocellular Type.
Human pathology 2017 Apr . Chen Jun, He Jian, Deng Min, Wu Hong-Yan, Shi Jiong, Mao Liang, Sun Qi, Tang Min, Fan Xiang-Shan, Qiu Yu-Dong, Huang Q |
|
Biliary cancer: Utility of next-generation sequencing for clinical management.
Cancer 2016 Sep . Javle Milind, Bekaii-Saab Tanios, Jain Apurva, Wang Ying, Kelley Robin Katie, Wang Kai, Kang Hyunseon C, Catenacci Daniel, Ali Siraj, Krishnan Sunil, Ahn Daniel, Bocobo Andrea Grace, Zuo Mingxin, Kaseb Ahmed, Miller Vincent, Stephens Philip J, Meric-Bernstam Funda, Shroff Rachna, Ross Jeffr |
|
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Annals of surgical oncology 2015 Dec . Ruzzenente Andrea, Fassan Matteo, Conci Simone, Simbolo Michele, Lawlor Rita T, Pedrazzani Corrado, Capelli Paola, D'Onofrio Mirko, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
|
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma.
The oncologist 2015 Sep 20 (9): 1019-27. Goyal Lipika, Govindan Aparna, Sheth Rahul A, Nardi Valentina, Blaszkowsky Lawrence S, Faris Jason E, Clark Jeffrey W, Ryan David P, Kwak Eunice L, Allen Jill N, Murphy Janet E, Saha Supriya K, Hong Theodore S, Wo Jennifer Y, Ferrone Cristina R, Tanabe Kenneth K, Chong Dawn Q, Deshpande Vikram, Borger Darrell R, Iafrate A John, Bardeesy Nabeel, Zheng Hui, Zhu Andrew |
|
Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
Experimental and molecular pathology 2015 Aug 99 (2): 344-353. Arnold Alexander, Bahra Marcus, Lenze Dido, Bradtmöller Maren, Guse Katrin, Gehlhaar Claire, Bläker Hendrik, Heppner Frank L, Koch Are |
|
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
Annals of surgical oncology 2014 Nov 21 (12): 3827-34. Zhu Andrew X, Borger Darrell R, Kim Yuhree, Cosgrove David, Ejaz Aslam, Alexandrescu Sorin, Groeschl Ryan Thomas, Deshpande Vikram, Lindberg James M, Ferrone Cristina, Sempoux Christine, Yau Thomas, Poon Ronnie, Popescu Irinel, Bauer Todd W, Gamblin T Clark, Gigot Jean Francois, Anders Robert A, Pawlik Timothy |
|
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.
Oncotarget 2014 May 5 (9): 2839-52. Simbolo Michele, Fassan Matteo, Ruzzenente Andrea, Mafficini Andrea, Wood Laura D, Corbo Vincenzo, Melisi Davide, Malleo Giuseppe, Vicentini Caterina, Malpeli Giorgio, Antonello Davide, Sperandio Nicola, Capelli Paola, Tomezzoli Anna, Iacono Calogero, Lawlor Rita T, Bassi Claudio, Hruban Ralph H, Guglielmi Alfredo, Tortora Giampaolo, de Braud Filippo, Scarpa Al |
|
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Apr 20 (7): 1884-90. Borger Darrell R, Goyal Lipika, Yau Thomas, Poon Ronnie T, Ancukiewicz Marek, Deshpande Vikram, Christiani David C, Liebman Hannah M, Yang Hua, Kim Hyeryun, Yen Katharine, Faris Jason E, Iafrate A John, Kwak Eunice L, Clark Jeffrey W, Allen Jill N, Blaszkowsky Lawrence S, Murphy Janet E, Saha Supriya K, Hong Theodore S, Wo Jennifer Y, Ferrone Cristina R, Tanabe Kenneth K, Bardeesy Nabeel, Straley Kimberly S, Agresta Sam, Schenkein David P, Ellisen Leif W, Ryan David P, Zhu Andrew |
|
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
PloS one 2014 9 (12): e115383. Churi Chaitanya R, Shroff Rachna, Wang Ying, Rashid Asif, Kang HyunSeon C, Weatherly Jacqueline, Zuo Mingxin, Zinner Ralph, Hong David, Meric-Bernstam Funda, Janku Filip, Crane Christopher H, Mishra Lopa, Vauthey Jean-Nicholas, Wolff Robert A, Mills Gordon, Javle Mili |
|
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.
Nature genetics 2013 Dec 45 (12): 1474-8. Chan-On Waraporn, Nairismägi Maarja-Liisa, Ong Choon Kiat, Lim Weng Khong, Dima Simona, Pairojkul Chawalit, Lim Kiat Hon, McPherson John R, Cutcutache Ioana, Heng Hong Lee, Ooi London, Chung Alexander, Chow Pierce, Cheow Peng Chung, Lee Ser Yee, Choo Su Pin, Tan Iain Bee Huat, Duda Dan, Nastase Anca, Myint Swe Swe, Wong Bernice Huimin, Gan Anna, Rajasegaran Vikneswari, Ng Cedric Chuan Young, Nagarajan Sanjanaa, Jusakul Apinya, Zhang Shenli, Vohra Priya, Yu Willie, Huang DaChuan, Sithithaworn Paiboon, Yongvanit Puangrat, Wongkham Sopit, Khuntikeo Narong, Bhudhisawasdi Vajaraphongsa, Popescu Irinel, Rozen Steven G, Tan Patrick, Teh Bin Te |
|
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
Oncogene 2013 Jun 32 (25): 3091-100. Wang P, Dong Q, Zhang C, Kuan P-F, Liu Y, Jeck W R, Andersen J B, Jiang W, Savich G L, Tan T-X, Auman J T, Hoskins J M, Misher A D, Moser C D, Yourstone S M, Kim J W, Cibulskis K, Getz G, Hunt H V, Thorgeirsson S S, Roberts L R, Ye D, Guan K-L, Xiong Y, Qin L-X, Chiang D |
|
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.
Human pathology 2013 Feb . Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, Highsmith WE, Halling KC, Kipp BR |
|
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma.
Human pathology 2012 Oct 43 (10): 1552-8. Kipp Benjamin R, Voss Jesse S, Kerr Sarah E, Barr Fritcher Emily G, Graham Rondell P, Zhang Lizhi, Highsmith W Edward, Zhang Jun, Roberts Lewis R, Gores Gregory J, Halling Kevin |
|
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.
The oncologist 2012 17 (1): 72-9. Borger Darrell R, Tanabe Kenneth K, Fan Kenneth C, Lopez Hector U, Fantin Valeria R, Straley Kimberly S, Schenkein David P, Hezel Aram F, Ancukiewicz Marek, Liebman Hannah M, Kwak Eunice L, Clark Jeffrey W, Ryan David P, Deshpande Vikram, Dias-Santagata Dora, Ellisen Leif W, Zhu Andrew X, Iafrate A Jo |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 10, 2019
- Content source: